BriaCell Therapeutics Corp. (TSX:BCT)
Canada · Delayed Price · Currency is CAD 5.50
-0.04 (-0.72%)
At close: Mar 3, 2026
BriaCell Therapeutics Market Cap
BriaCell Therapeutics has a market cap or net worth of CAD 39.88 million as of March 4, 2026. Its market cap has increased by 98.71% in one year.
Market Cap
39.88M
Enterprise Value
24.74M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.50
Market Cap Chart
Since December 3, 2014, BriaCell Therapeutics's market cap has increased from 24.42M to 39.88M, an increase of 63.32%. That is a compound annual growth rate of 4.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 40.17M | 117.57% |
| Dec 31, 2025 | 18.46M | -48.44% |
| Dec 31, 2024 | 35.81M | -71.28% |
| Dec 29, 2023 | 124.66M | 36.15% |
| Dec 30, 2022 | 91.56M | -44.85% |
| Dec 31, 2021 | 166.03M | 3,496.79% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medicenna Therapeutics | 72.58M |
| Sharp Therapeutics | 67.67M |
| NurExone Biologic | 58.99M |
| MedMira | 48.82M |
| Sernova Biotherapeutics | 47.47M |
| Devonian Health Group | 38.03M |
| Defence Therapeutics | 35.00M |
| Resverlogix | 34.73M |